Kamal K. Mubarak

Medicine · Health Sciences

17h-index3.6kcitations41works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pulmonary Hypertension Research and Treatments(17), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(7), Hemoglobinopathies and Related Disorders(6), Systemic Sclerosis and Related Diseases(5), Cardiovascular Issues in Pregnancy(4)

Publications41 total

Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies
UNC Libraries·2020Open Access
Pulmonary Hypertension of Sickle Cell Disease Beyond Classification Constraints
Journal of the American College of Cardiology·2014· 2 cited
An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease
American Journal of Respiratory and Critical Care Medicine·2014· 248 cited
A lost guidewire
Indian Journal of Critical Care Medicine·2014· 7 citedOpen Access
Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models
American Journal of Respiratory and Critical Care Medicine·2013· 173 citedOpen Access
Hypoxia-induced endothelial CX3CL1 triggers lung smooth muscle cell phenotypic switching and proliferative expansion
American Journal of Physiology-Lung Cellular and Molecular Physiology·2012· 38 citedOpen Access
Echocardiographic Evaluation of Patients With Sickle Cell Disease
CHEST Journal·2011· 1 cited
Hemodynamic Characteristics of Sickle Cell Disease Patients Undergoing Right Heart Catheterizatio
CHEST Journal·2011Open Access
Pulmonary Arterial Hypertension
American Journal of Therapeutics·2011· 9 cited
Value of Impedance Cardiography in Patients Studied for Pulmonary Hypertension
Lung·2011· 48 cited
Hypoxia-Induced Endothelial CX3CL1 Modulation Triggers Lung Smooth Muscle Cell Proliferation
2011· 1 cited
Effect of Balloon Inflation Volume on Pulmonary Artery Occlusion Pressure in Patients With and Without Pulmonary Hypertension
CHEST Journal·2011· 52 citedOpen Access
Value of Impedance Cardiography in Pulmonary Hypertension
CHEST Journal·2010· 3 cited
Treating Pulmonary Vascular Disease in the Developing World
CHEST Journal·2010· 1 citedOpen Access
Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival
The Journal of Heart and Lung Transplantation·2010· 51 cited
CHEMOKINE CX3CL1 AND PULMONARY HYPERTENSION: ROLE OF MONONUCLEAR LEUKOCYTE INTERACTION WITH LUNG MICROVASCULAR ENDOTHELIAL CELLS EX VIVO
2010
Pleural Mesothelial Plasticity And Trafficking In Idiopathic Pulmonary Fibrosis. Does Pleural Epithelial-Mesenchymal Transition Cause IPF?
2010
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies
British Journal of Haematology·2010· 128 citedOpen Access
Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension
Respiratory Medicine·2009· 107 citedOpen Access
INCIDENCE AND FACTORS ASSOCIATED WITH PULMONARY HYPERTENSION IN PATIENTS WITH ADVANCED LUNG DISEASE EVALUATED FOR LUNG TRANSPLANTATION
CHEST Journal·2009
page 1 of 3Next →

Frequent Co-authors

Hassan Alnuaimat(8), Robin D. Carrie(8), Adriano R. Tonelli(7), Donald P. Tashkin(4), Robert M. Elashoff(4), Philip J. Clements(4), Michael D. Roth(4), Richard M. Silver(4), James R. Seibold(4), John Varga(4), Arthur C. Theodore(4), Virginia Steen(4), Maureen D. Mayes(4), M. Kari Connolly(4), Barri J. Fessler(4), Naomi F. Rothfield(4), Oswaldo Castro(4), Mark T. Gladwin(4), Jawaharlal M. Patel(4), Kamal A. Mohammed(4)